Skip to content
Screener

CONMED CNMD Orthopedic Surgery — Net Sales

Other product segments

General Surgery
$191.17M-5.2%

Similar metrics at other companies

Baxter International logo
BAXAdvanced Surgery — Net Sales
$304M+13.4%
Stryker logo
SYKOrthopaedic Instruments — Net Sales
$489M+1.0%
Stryker logo
SYKOther Orthopedics — Net Sales
$157M+18.0%
Stryker logo
SYKOrthopaedics: — Net Sales
$2.81B+0.1%
General Mills logo
GISPet — Net Sales
$746.6M+5.8%
Wabash National logo
WNCNew trailers — Net Sales
$317.05M+1.6%

Other financials

Income statement

See full
Revenue$343.5M+0.3%
Gross profit$197.5M+4.9%
Operating income$36.4M-4.6%
Net income$23.1M+7.7%
EPS (diluted)$0.77+11.6%

Balance sheet

See full
Cash & equivalents$37.3M+10.0%
Total debt$1.0B+14.5%
Total equity$1.0B+3.8%
Total assets$2.3B-1.2%

Cash flow

See full
Operating cash flow$37.1M+27.3%
CapEx$2.9M-48.8%
Free cash flow$34.2M+46.0%

Valuation

See full
Market cap$1.47B-9.4%
Enterprise value$2.45B-1.1%
P/E26×+11.3×
P/S1.1×-0.2×

Profitability

See full
Gross margin55.8%-0.3pp
Operating margin8%-5.0pp
Net margin4.1%-4.2pp
FCF margin9.8%-1.4pp

Returns & leverage

See full
Return on equity5.5%-6.2pp
Debt / equity+0.1×
Current ratio1.5×-0.7×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: CONMED’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000816956-26-000102
Line itemThree Months Ended / June 30, 2026 / Orthopedic SurgeryThree Months Ended / June 30, 2026 / General SurgeryThree Months Ended / June 30, 2026 / TotalThree Months Ended / June 30, 2025 / Orthopedic SurgeryThree Months Ended / June 30, 2025 / General SurgeryThree Months Ended / June 30, 2025 / Total
Europe, Middle East & Africa40,30535,84276,14735,58832,18967,777
Asia Pacific36,56120,59657,15731,73620,34552,081
Americas (excluding the United States)23,79611,00334,79921,72310,15231,875
Total sales from contracts with customers$152,315$191,173$343,488$140,734$201,611$342,345
Timing of Revenue Recognition
Goods transferred at a point in time$139,852$188,205$328,057$129,382$199,065$328,447
Services transferred over time12,4632,96815,43111,3522,54613,898
Total sales from contracts with customers$152,315$191,173$343,488$140,734$201,611$342,345

Item 1. Financial Statements (unaudited)

FAQ

What is CONMED's orthopedic surgery — net sales?
CONMED (CNMD) reported orthopedic surgery — net sales of $152.32M in Q2 2026.
How has CONMED's orthopedic surgery — net sales changed year-over-year?
CONMED's orthopedic surgery — net sales increased by 8.2% year-over-year, from $140.73M to $152.32M.
What is the long-term trend for CONMED's orthopedic surgery — net sales?
Over 4 years (2021 to 2025), CONMED's orthopedic surgery — net sales has grown at a 7.0% compound annual growth rate (CAGR), from $438.43M to $574.6M.
What does orthopedic surgery — net sales mean?
This metric represents the total revenue generated from the sale of medical devices, instruments, and implants specifically designed for orthopedic surgical procedures. It serves as a key indicator of the company's market penetration and demand within the sports medicine and musculoskeletal surgery sectors. Tracking this figure allows investors to evaluate the growth trajectory and competitive performance of the orthopedic product portfolio relative to broader surgical market trends.

Ask your AI about CONMED's orthopedic surgery — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude